GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (OTCPK:GRRMY) » Definitions » YoY EPS Growth

Gerresheimer AG (Gerresheimer AG) YoY EPS Growth : 0.00% (As of Feb. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Gerresheimer AG YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Gerresheimer AG's YoY EPS Growth for the quarter that ended in Feb. 2024 was 0.00%.

Gerresheimer AG's Earnings per Share (Diluted) for the three months ended in Feb. 2024 was $0.10.

Gerresheimer AG YoY EPS Growth Historical Data

The historical data trend for Gerresheimer AG's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG YoY EPS Growth Chart

Gerresheimer AG Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -39.21 17.32 -8.52 2.36 20.77

Gerresheimer AG Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.25 35.07 0.45 23.13 -

Gerresheimer AG YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Gerresheimer AG's YoY EPS Growth for the fiscal year that ended in Nov. 2023 is calculated as:

YoY EPS Growth (A: Nov. 2023 )
=(Earnings per Share (Diluted) (A: Nov. 2023 )-Earnings per Share (Diluted) (A: Nov. 2022 ))/ | Earnings per Share (Diluted) (A: Nov. 2022 ) |
=(0.942-0.78)/ | 0.78 |
=20.77 %

Gerresheimer AG's YoY EPS Growth for the quarter that ended in Feb. 2024 is calculated as:

YoY EPS Growth (Q: Feb. 2024 )
=(Earnings per Share (Diluted) (Q: Feb. 2024 )-Earnings per Share (Diluted) (Q: Feb. 2023 )) / | Earnings per Share (Diluted) (Q: Feb. 2023 )) |
=(0.102-0.102)/ | 0.102 |
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gerresheimer AG YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Gerresheimer AG (Gerresheimer AG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (OTCPK:GRRMY) » Definitions » YoY EPS Growth
Comparable Companies
XTER:FIE XTER:1SXP FRA:PHH2 XTER:AFX ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD OCSE:COLO B TSE:4543 WST XSWX:STMN XPAR:DIM TSE:7733 COO BAX HOLX TSE:6869
Traded in Other Exchanges
GXId:UK 0NTI:UK GXI:Germany GXI:Austria
Address
Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Website
https://www.gerresheimer.com
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.

Gerresheimer AG (Gerresheimer AG) Headlines

From GuruFocus

Gerresheimer Business Model Robust

By PRNewswire PRNewswire • 04-09-2020

Leading Pharma Packaging Companies Commit to Supply for Covid-19 Fight

By PRNewswire PRNewswire • 06-16-2020

Gerresheimer AG: Gerresheimer Continues Dynamic Growth in First Half of 2023

By ACCESSWIRE • 07-06-2023

Gerresheimer With Strong Second Quarter

By PRNewswire PRNewswire • 07-14-2020

Gerresheimer Business Model Robust

By PRNewswire PRNewswire • 04-09-2020

Gerresheimer awarded EcoVadis Gold status again

By PRNewswire • 10-18-2023